Emerging Roles of Nanocarriers in Cancer Therapy.



Emerging Roles of Nanocarriers in Cancer Therapy. - London | CRC Press | 2025.

This book addresses the limitations of existing therapeutic approaches using nanoparticles. Emerging Roles of Nanocarriers in Cancer Therapy will further provide information for the development of successful cancer nanomedicine therapies.

Features

Explains different types of nanoparticles, targeting mechanisms, and approved nanotherapeutics for oncological implications in cancer treatment. Covers in detail the characteristics of various nanotechnology-based drug delivery systems. Discusses passive and active cellular targeting, ligand-based targeting of nanoparticles, and strategies to improve nanoparticle-cellular membrane interaction. Presents the application of nanotherapeutics, current challenges, and prospects, and describes the path of future research. Highlights smart strategies for improving the clinical impact of cancer nanomedicine.

The text is primarily written for graduate students, and academic researchers in the fields of biotechnology, nanotechnology, drug delivery, pharmaceutical science, and pharmacology.

9781032583525 9781032586748 9781003451020 = acid active targeting adjuvant Adv Drug Deliv agents amphiphilic angiogenesis antibodies antigens antitumor applications biocompatibility biological breast cancer cancer cells cancer immunotherapy cancer nanomedicine cancer therapy cancer treatment carriers cellular targeting cellular uptake Chem chemotherapeutic chemotherapy Chen cisplatin combination therapy Control Release dendrimers DOX doxorubicin Drug Deliv Rev drug delivery drug delivery systems drug release efficacy encapsulated endocytosis endosomes enhanced gene H HBO HBOT HPMA hydrophilic hydrophobic hyperbaric oxygen therapy hypoxia imaging immune system improve increase Int interactions intracellular ligands lipid liposomes Liu medication medicines membrane metastatic methods mice micelles Mol molecular molecules Nano nanocarriers nanomedicine nanoparticles nanoscale nanotechnology Nat Rev NPs Oncol paclitaxel particles patients peptides pH Pharm pharmaceutical polymer polymer-drug conjugates polymeric polymeric micelles polymeric nanoparticles potential preclinical protein radiation receptors resistance RNA Sci siRNA siRNA delivery solid tumors strategies surface synergistic targeted cancer techniques theranostic therapeutic toxicity tumor tumor cells vitro vivo Wang Zhang
Catholic University of  Health and Allied Sciences - CUHAS
Directorate of ICT @ 2024